Online Training for Healthcare Professionals: a Possible Strategy for Prevention of Burnout

March 22, 2022 updated by: Carlos Vicente Serrano Jr, University of Sao Paulo General Hospital

Effects of Online Training on Self-esteem and Occupational Stress of Healthcare Professionals: a Possible Strategy for Prevention of Burnout Syndrome.

This study aims to evaluate the effects of online training on self-esteem and occupational stress of healthcare professionals, in order to evaluate the potential of this intervention as a preventive measure to Burnout syndrome. The study will be developed in three phases,the first being the period of one week before the intervention(t0), when instruments will be first applied.The second phase corresponds to intervention period, when the instruments will be reapplied after the second (t1), third (t2) and fourth (t3) training intervention. The third phase corresponds to the follow up (t4-t8), when all instruments used in the second phase will be reapplied in 2 months (t4), 4 months (t5), 6 months (t6), 8 months (t7) and 12 months (t8) after the end of the intervention.

The sample will consist of 100 health professionals randomized into two groups (50 in each group): intervention group (I), formed by those who will participate in the online training and control group (C), formed by those who will receive the intervention after research is finished.

The hypotheses are: the online training will have greater effect on the increase of self-esteem, and will be identified in health professionals: low levels of global self-esteem, high levels of occupational stress and average levels of burnout.

Study Overview

Status

Recruiting

Conditions

Study Type

Interventional

Enrollment (Anticipated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • São Paulo, Brazil, 05403-900
        • Recruiting
        • Heart Institute of the Hospital das Clínicas, University of São Paulo Medical School
        • Contact:
          • Phone Number: 2661-5352

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Health professionals who work at University of Sao Paulo General Hospital
  • Agree and sign the Inform Consent Form.

Exclusion Criteria:

  • Those who, one week before training, presents anxiety and depressive symptoms (GAD ≥ 14 e/ou PHQ ≥ 14)
  • in psychotherapy during data collection;
  • diagnosed with Burnout syndrome.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention group (I)
Online training for healthcare professionals which will follow a protocol made especially for this research. The online training is composed by 4 modules and each module has 3 meetings. Each meeting has 35 minutes long.

The online training (4 modules) will use the technique of hybrid learning, combining meetings that will require the presence of participants and mediator at the same time and platform (live) with recorded meetings (interviews with experts) that will be watched by the participants at any time (from a distance).

Module 1: Self Care; Module 2: Stress and anxiety management; Module 3: Relationships; Module 4: Communication.

No Intervention: Control group (C)
No intervention. The control group will receive the intervention after study is completed.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Self esteem
Time Frame: Through study completion, an average of 1 year and 4 months
Assessed by the instrument Rosenberg Self Esteem Scale(RSES)
Through study completion, an average of 1 year and 4 months
Occupational Stress
Time Frame: Through study completion, an average of 1 year and 4 months
Assessed by the instrument Stress Questionnaire for Health Professionals (SQHP)
Through study completion, an average of 1 year and 4 months
Burnout
Time Frame: Through study completion, an average of 1 year and 4 months
Assessed by the instrument Copenhagen Burnout Inventory(CBI)
Through study completion, an average of 1 year and 4 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Anxiety
Time Frame: Through study completion, an average of 1 year and 4 months
Assessed by the instrument Generalized Anxiety Disorder-7 (GAD-7)
Through study completion, an average of 1 year and 4 months
Depression
Time Frame: Through study completion, an average of 1 year and 4 months
Assessed by the instrument Patient Health Questionnaire - 9 (PHQ-9)
Through study completion, an average of 1 year and 4 months
Covid-19 impact
Time Frame: Through study completion, an average of 1 year and 4 months
Assessed by the instrument Impact of Event Scale - Revised (IES -Rs)
Through study completion, an average of 1 year and 4 months
Improvement in general health after entering the study.
Time Frame: Through study completion, an average of 1 year and 2 months
Assessed by the instrument Patient Global Improvement Change Scale (PGIC)
Through study completion, an average of 1 year and 2 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Patrícia Perniciotti Almeida Costa, Phd student, University of Sao Paulo Medical School

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 10, 2022

Primary Completion (Anticipated)

July 1, 2023

Study Completion (Anticipated)

December 1, 2023

Study Registration Dates

First Submitted

March 10, 2022

First Submitted That Met QC Criteria

March 22, 2022

First Posted (Actual)

March 31, 2022

Study Record Updates

Last Update Posted (Actual)

March 31, 2022

Last Update Submitted That Met QC Criteria

March 22, 2022

Last Verified

March 1, 2022

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Burnout

Clinical Trials on Online training for healthcare professionals

Subscribe